Plain-English translation of NCT06941948 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why sleep problems are so common in lung cancer patients and how poor sleep might affect the body's ability to fight cancer. The study will compare lung cancer patients who have sleep disorders with those who don't, tracking them for 1–3 years to see if sleep quality influences how well the immune system works and how patients respond to treatment.
Up to 7 in 10 lung cancer patients struggle with sleep problems, and early research suggests this might weaken the immune system's ability to fight cancer. However, no large-scale studies have clearly proven this connection in humans, so this research aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
You will be asked to complete a sleep quality questionnaire to assess your sleep patterns. Researchers will then follow you over 1–3 years, monitoring your health outcomes, immune markers, and how you respond to cancer treatment. You'll be grouped based on your sleep quality, and the study will track whether sleep disorders affect your cancer progression and treatment response.
AI-generated summary from trial data · Nov 13, 2026 · Not medical advice
China
Shanghai Zhongshan Hospital
Enrollment target
~400 participants
Started
May 2025
Primary completion
January 2027
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
PAN JIANG, PHD
Shanghai Zhongshan Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.